[{"Assets_0_Q3_USD":4558128000.0,"EarningsPerShareDiluted_3_Q3_USD":-0.22,"EarningsPerShareDiluted_1_Q3_USD":0.3,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":178873000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":179289000.0,"EarningsPerShareBasic_3_Q3_USD":-0.22,"EarningsPerShareBasic_1_Q3_USD":0.31,"RevenuesConverted_1_Q3_USD":461097000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":178873000.0,"StockholdersEquity_0_Q3_USD":3074405000.0,"NetIncomeLossConverted_3_Q3_USD":-38872000.0,"NetIncomeLossConverted_1_Q3_USD":55036000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":-9081000.0,"CommonStockSharesOutstanding_0_Q3_shares":179604381.0,"CommonStockSharesConverted_0_Q3_shares":179604381.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":185924000.0,"RevenuesConverted_3_Q3_USD":1249605000.0,"Ticker":"BMRN","CIK":"1048477","name":"BIOMARIN PHARMACEUTICAL INC","OfficialName":"BioMarin Pharmaceutical Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"14899091235.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191029"}]